GPGilles Plourde

Gilles Plourde

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gilles Plourde has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of Isoflurane on the Auditory Steady-state Response and on Consciousness in Human Volunteers

    by Gilles Plourde, Chantal Villemure, Pierre Fiset, Vincent Bonhomme, Steven B. Backman

    Background: The auditory steady state response (ASSR) is a sustained electrical response of the brain to auditory stimuli delivered at fast rates (30-50 responses/s). The aim of this study was to evaluate the effect of 0.26-0.50% isoflurane on the ASSR and on consciousness, defined as responsiveness to verbal commands. Methods: Ten volunteers (21-31 yr) participated. Isoflurane was administered at three stable, end-tidal concentrations: 0.26%, 0.38%, and 0.50%. The ASSR in response to 18,000 stimuli (500-Hz tonebursts, 10 ms, 82-dB, the right ear, 35-45 bursts/s) was recorded from the vertex with reference to the right mastoid. Recordings were made during baseline, at each isoflurane concentration, and during recovery. Results: The mean (SD) ASSR amplitudes were 0.32 (0.23) microV during baseline, 0.24 (0.17) microV during 0.26% isoflurane, 0.09 (0.05) microV during 0.38% isoflurane, 0.04 (0.03) microV during 0.50% isoflurane, and 0.29 (0.33) microV during recovery. The amplitude during baseline and recovery was larger than during 0.38% and 0.50% isoflurane (P < 0.001). The amplitude at 0.26% was larger than at the other concentrations (P < 0.025). The logarithm of the ASSR amplitude was related linearly to the concentration of isoflurane (r = 0.85; P < 0.0001). The prediction probability (Pk) for loss of consciousness was 0.95 for both ASSR and measured isoflurane concentration. An ASSR amplitude < 0.07 microV was always associated with unconsciousness. Conclusions: The ASSR is attenuated in a concentration-dependent manner by isoflurane. Suppression of consciousness and maximal attenuation of ASSR occur in the same isoflurane concentration range. Profound attenuation of ASSR appears to reflect unconsciousness, defined as unresponsiveness to verbal commands.


  • Open Access

    40 Hz Auditory steady-state response and EEG spectral edge frequency during sufentanil anaesthesia

    by I. Gilron, G. Plourde, W. Marcantoni, F. Varin

    The auditory steady-state evoked response (ASSR) is an evoked potential which provides a sensitive measure of the effects of general anaesthetics on the brain. We used pharmacokinetic-pharmacodynamic (PK-PD) modelling to compare the effects of sufentanil on the amplitude of the ASSR with its effect on spectral edge frequency (SEF) of the electroencephalogram. Nine patients scheduled for elective cardiac surgery participated. Midazolam (70 μg·kg−1 im) was given 60 min before entering the operating room. Anaesthesia was induced with 5 μg·kg−1 sufentanil at a rate of 0.83 μg·kg−1·min−1. The ASSR, SEF and plasma sufentanil concentrations were measured for 30 min ater induction of anaesthesia before surgery. The half-life between the central and effect site compartments (t1/2Keo), the 50% inhibitory concentration (IC50) and the slope factor (gamma) were computed. The amplitude of the ASSR increased during the first three minutes of infusion of sufentanil by up to 40%. This was followed by a rapid decrease between the fourth and fifth minutes to 16% of baseline. The SEF decreased progressively during the first five minutes of infusion to 18% of baseline. Both measures subsequently showed modest recovery. The parameters gamma, IC50 and t1/2Keofor ASSR were (mean ±SD) 6,0 ±3.7, 2.1 ±1,2 ng·ml−1 and 7.3 ±2.4 min. For SEF the values were 5.9 ±5.2, 1.4 ±0.7 ng·ml−1 (P < 0.05 compared with ASSR) and 6.8 ±2,4 min. The sensitivity of ASSR to sufentanil is less than that of the SEF. La réponse auditive soutenue (RAS) est un potentiel évoqué auditif qui constitue une mesure très sensible des effets des anesthésiques généraux sur le cerveau. Nous avons utilisé un modèle pharmacocinétique/pharmacodynamique pour comparer les effets du sufentanil sur l’amplitude de la RAS avec ses effets sur la fréquence de puissance quantile 95% (F95) de l’électroencéphalogramme. Neuf patients devant subir une chirurgie cardiaque programmée ont participé à l’étude. Du midazolam (70 μg·kg−1 im) a été administré une heure avant l’entrée en salle d’opération. Nous avons induit l’anesthésie avec une perfusion de sufentanil (5μg·kg−1) à un débit de 0.83 μg·kg−1·min−1. Avant le début de la chirurgie, nous avons mesuré la RAS, F95 et la concentration plasmatique de sufentanil à plusieurs reprises pendant 30 minutes. Nous avons calculé la demi-vie de transfert entre le compartiment central et le compartiment effecteur (t1/2Keo, la concentration inhibitrice 50% (Cl50) ainsi que le pente (gamma) de le courbe concentration-réponse. Lamplitude de la RAS a augmenté de 40% pendant les trois premières minutes de la perfusion de sufentanil pour ensuite chuter de façon abrupte lors des deux minutes subséquentes et atteindre 16% du niveau de base. La F95 a diminué de manière progressive durant les cinq premières minutes de la perfusion pour atteindre 18% du niveau de base. Les deux mesures ont par le suite augmenté de façon modeste. Les paramètres gamma, Cl50 et T1/2Keo pour la RAS étaient (moyenne ±écart type) 6.0 ±3.7, 2.1 ±1.2 mg·ml−1 et 7.3 ±2.4 min. Pour la F95, les valeurs étaient 5.9 ±5.2, 1.4 ±0.7 mg·mh−1 (P< 0.05 en comparaison avec la RAS) et 6.8 ±2.4 min. La RAS est une mesure moins sensible que la F95 pour évaluer les effets du sufentanil sur le cerveau.


  • Temperature during cardiopulmonary bypass for coronary artery operations does not influence postoperative cognitive function: A prospective, randomized trial

    by Gilles Plourde, Annie Sapin Leduc, Jean E. Morin, Benoit DeVarennes, David Latter, James Symes, Ross Robbins, Nadine Fosset, Lucie Couture, Alain Ptito


  • Unintentional intraoperative awareness during sufentanil anaesthesia for cardiac surgery

    by I. Gilron, P. Solomon, G. Plourde

    The aim of this clinical report is to describe a case of unintentional intraoperative awareness during sufentanil anaesthesia in a patient undergoing elective aortocoronary bypass grafting. After premedication with morphine (5 mg) and scopolamine (0.2 mg), this 51-yr-old woman received sufentanil (10 μg · kg−1), midazolam (4 mg) and isoflurane (0.3–0.4% end-tidal). The patient recalled specific events and discussions which took place in the operating room during surgery. This patient’s report was clear and corroborated by operating room personnel. The patient denied having felt pain, anxiety or emotional distress. Although awareness during opioid anaesthesia has been previously described with morphine and fentanyl, as far as we know this is the first clinical report of awareness with sufentanil. Given that recent efforts of early extubation in cardiac surgery patients may involve a reduction in the amount of opioid administered, this report serves as a reminder of the ever present potential for this disturbing complication. Rapporter une observation de reprise accidentelle de la conscience pendant l’anesthésie au sufentanil d’une patiente opérée pour une chirurgie de revascularisation myocardique non urgente. Après une prémédication à la morphine (5 mg) et à la scopolamine (0,2 mg) cette patiente de 51 ans a reçu du sufentanil (10 μg · kg−1), du midazolam (4 mg) et de l’isoflurane (téléexpiratoire 0,2–0,4%). La patiente s’est souvenue des événements spécifiques et des discussions qui se sont déroulées en salle d’opération pendant la chirurgie. Les faits rapportés étaient précis et ont été corroborés par le personnel de la salle d’opération. La patiente a nié avoir ressenti de la douleur, de l’anxiété ou de la détresse émotionnelle. La reprise de conscience a déjà été rapportée avec la morphine et le fentanyl, mais d’après les auteurs, il s’agit ici du premier cas mettant en cause le sufentanil. Etant donné la tendance actuelle vers l’extubation précoce pouvant nécessiter une réduction de la quantité de morphinique, l’observation actuelle nous rappelle le danger constant de cette inquiétante complication.